Premium
Prevention of estradiol‐induced endometrial hyperplasia with either transdermal norethisterone acetate (NETA) 120μg or oral promegestone 500μG
Author(s) -
Calaf J.,
Pélissier C.,
Levrier M.,
Conesa A.,
Sarrazin B.,
Raynaud J.P.
Publication year - 2000
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(00)82358-9
Subject(s) - norethisterone , norethisterone acetate , medicine , endometrial hyperplasia , citation , estrogen , gynecology , transdermal , endocrinology , hyperplasia , library science , pharmacology , research methodology , population , environmental health , computer science